XLANDEXYS Trademark

Trademark Overview

On Monday, November 26, 2018, a trademark application was filed for XLANDEXYS with the United States Patent and Trademark Office. The USPTO has given the XLANDEXYS trademark a serial number of 88205717. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 27, 2022. This trademark is owned by KemPharm, Inc.. The XLANDEXYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, pain, central nervous system disorders, and psychiatric diseases and disorders
xlandexys

General Information

Serial Number88205717
Word MarkXLANDEXYS
Filing DateMonday, November 26, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 27, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, pain, central nervous system disorders, and psychiatric diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 13, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKemPharm, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCelebration, FL 34747
Party NameKemPharm, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoralville, IA 52241

Trademark Events

Event DateEvent Description
Monday, June 27, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 27, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 30, 2021SOU EXTENSION 5 GRANTED
Sunday, November 21, 2021SOU EXTENSION 5 FILED
Tuesday, November 30, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, November 21, 2021SOU TEAS EXTENSION RECEIVED
Saturday, May 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2021SOU EXTENSION 4 GRANTED
Thursday, May 20, 2021SOU EXTENSION 4 FILED
Thursday, May 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 13, 2020SOU EXTENSION 3 GRANTED
Friday, November 13, 2020SOU EXTENSION 3 FILED
Friday, November 13, 2020SOU TEAS EXTENSION RECEIVED
Saturday, May 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 21, 2020SOU EXTENSION 2 GRANTED
Thursday, May 21, 2020SOU EXTENSION 2 FILED
Thursday, May 21, 2020SOU TEAS EXTENSION RECEIVED
Thursday, November 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 19, 2019SOU EXTENSION 1 GRANTED
Tuesday, November 19, 2019SOU EXTENSION 1 FILED
Tuesday, November 19, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, May 21, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 30, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2019ASSIGNED TO EXAMINER
Thursday, December 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 29, 2018NEW APPLICATION ENTERED

Related Keywords

xlandexys disorders nervous central system pain psychiatric diseases disorder treatment preparations